Knowledge (XXG)

Sarah Blagden

Source 📝

31: 81:. Her laboratory research is in investigating post-transcriptional mechanisms for ovarian cancer behavior. Her clinical research is in conducting early phase trials in novel cancer therapeutics for people with advanced malignancies. 135:
in 2006 and became a Director of Imperial's Early Cancer Trials Unit. While at Imperial, Blagden established a laboratory studying the dysregulation of mRNA translation in cancer. This group was the first to describe the human gene
143:
Blagden was also a chief/Principal investigator for a number of national and international clinical studies. She is a Researcher and Professor of Experimental Oncology at the University of Oxford in the
229: 421: 436: 431: 416: 150:
She was a cofounder of the LARP Society, a scientific society dedicated to the study of La-related family of proteins. She serves on the Editorial Board of the
426: 145: 94: 411: 93:
a renowned mine clearance expert. She was educated in Haslemere in Surrey and later received a BSc in pharmacology in 1991 and a medical degree (MBBS) at
230:"Professor Sarah Blagden, Associate Professor of Experimental Cancer Therapeutics — University of Oxford, Medical Sciences Division" 401: 128: 104:
In 2004 she received a PhD (as CRUK Clinical Fellow) in fruit fly genetics in the laboratory of Prof David Glover at
406: 151: 116: 132: 105: 396: 124: 115:
After Blagden completed her medical training and subsequent specialist training in Medical Oncology at
98: 78: 348: 330: 338: 322: 131:'s Drug Development Unit. She was appointed to Senior Lecturer and Honorary Consultant at 343: 390: 366: 90: 202: 326: 30: 89:
Sarah Blagden was born in Aldershot, Hampshire in 1969. Her father was Brigadier
310: 285: 167:
CRUK Junior Clinician Scientist PhD fellowship in 1999 at Cambridge University
334: 309:
Blagden, Sarah P.; Bayfield, Mark; Bousquet-Antonelli, Cecile (2021-02-01).
120: 352: 254: 140:
and identify it as an RNA binding protein involved in ovarian cancer.
137: 155: 158:
a company dedicated to researching early cancer biomarkers.
170:
CRUK clinical Fellow PhD in 2004 at Cambridge University.
44:
Medical Degree (MBBS), PhD (as CRUK Clinical Fellow)
64: 56: 48: 40: 21: 127:she went on to hold a Clinical Fellowship at the 77:is a Professor of Experimental Oncology at the 173:Fellowship of Royal College Physicians in 2010 367:"Editorial Board | British Journal of Cancer" 8: 422:Medical scholars of the University of Oxford 95:Charing Cross and Westminster Medical School 68:University of Oxford, Department of Oncology 437:Fellows of the Royal College of Physicians 432:21st-century British women medical doctors 29: 18: 342: 183: 16:Researcher (ORCID 0000–0001-8783-3491) 417:Alumni of the University of Cambridge 255:"Sarah Blagden (0000-0001-8783-3491)" 7: 427:21st-century British medical doctors 280: 278: 276: 274: 224: 222: 197: 195: 193: 191: 189: 187: 412:Alumni of the University of London 52:Professor of Experimental Oncology 35:Photo: Matt Martin, Captis Imagery 14: 1: 327:10.1080/15476286.2020.1755505 129:Institute of Cancer Research 453: 311:"A decade of LARP society" 154:. In 2015 Blagden founded 286:"Home - Dr Sarah Blagden" 152:British Journal of Cancer 28: 85:Early life and education 146:department of oncology 125:Royal Marsden Hospital 117:Addenbrooke's Hospital 207:www.oncology.ox.ac.uk 106:Cambridge University 99:University of London 79:University of Oxford 402:British oncologists 234:www.medsci.ox.ac.uk 290:www.imperial.ac.uk 407:Women oncologists 72: 71: 57:Years active 444: 381: 380: 378: 377: 363: 357: 356: 346: 306: 300: 299: 297: 296: 282: 269: 268: 266: 265: 250: 244: 243: 241: 240: 226: 217: 216: 214: 213: 199: 133:Imperial College 33: 19: 452: 451: 447: 446: 445: 443: 442: 441: 387: 386: 385: 384: 375: 373: 365: 364: 360: 308: 307: 303: 294: 292: 284: 283: 272: 263: 261: 252: 251: 247: 238: 236: 228: 227: 220: 211: 209: 203:"Sarah Blagden" 201: 200: 185: 180: 164: 113: 91:Patrick Blagden 87: 65:Organization(s) 36: 24: 17: 12: 11: 5: 450: 448: 440: 439: 434: 429: 424: 419: 414: 409: 404: 399: 389: 388: 383: 382: 371:www.nature.com 358: 321:(2): 157–158. 301: 270: 245: 218: 182: 181: 179: 176: 175: 174: 171: 168: 163: 160: 112: 109: 86: 83: 70: 69: 66: 62: 61: 60:2015 - present 58: 54: 53: 50: 46: 45: 42: 38: 37: 34: 26: 25: 22: 15: 13: 10: 9: 6: 4: 3: 2: 449: 438: 435: 433: 430: 428: 425: 423: 420: 418: 415: 413: 410: 408: 405: 403: 400: 398: 397:Living people 395: 394: 392: 372: 368: 362: 359: 354: 350: 345: 340: 336: 332: 328: 324: 320: 316: 312: 305: 302: 291: 287: 281: 279: 277: 275: 271: 260: 256: 249: 246: 235: 231: 225: 223: 219: 208: 204: 198: 196: 194: 192: 190: 188: 184: 177: 172: 169: 166: 165: 161: 159: 157: 153: 148: 147: 141: 139: 134: 130: 126: 122: 118: 110: 108: 107: 102: 100: 96: 92: 84: 82: 80: 76: 75:Sarah Blagden 67: 63: 59: 55: 51: 47: 43: 39: 32: 27: 23:Sarah Blagden 20: 374:. Retrieved 370: 361: 318: 314: 304: 293:. Retrieved 289: 262:. Retrieved 258: 248: 237:. Retrieved 233: 210:. Retrieved 206: 156:RNA Guardian 149: 142: 114: 103: 88: 74: 73: 315:RNA Biology 391:Categories 376:2022-07-11 295:2021-03-01 264:2021-03-01 239:2021-03-01 212:2021-03-01 178:References 49:Occupation 335:1547-6286 259:orcid.org 121:Cambridge 101:in 1994. 41:Education 353:33651971 123:and the 344:7928030 253:ORCID. 351:  341:  333:  162:Awards 111:Career 138:LARP1 349:PMID 331:ISSN 339:PMC 323:doi 119:in 393:: 369:. 347:. 337:. 329:. 319:18 317:. 313:. 288:. 273:^ 257:. 232:. 221:^ 205:. 186:^ 97:, 379:. 355:. 325:: 298:. 267:. 242:. 215:.

Index


University of Oxford
Patrick Blagden
Charing Cross and Westminster Medical School
University of London
Cambridge University
Addenbrooke's Hospital
Cambridge
Royal Marsden Hospital
Institute of Cancer Research
Imperial College
LARP1
department of oncology
British Journal of Cancer
RNA Guardian






"Sarah Blagden"


"Professor Sarah Blagden, Associate Professor of Experimental Cancer Therapeutics — University of Oxford, Medical Sciences Division"
"Sarah Blagden (0000-0001-8783-3491)"



Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.